Influence of cannabinoids on immunoreactivity of regulatory peptides, produced in rat thyroid C cells; preliminary investigations

Rocz Akad Med Bialymst. 2004:49 Suppl 1:143-5.

Abstract

Mammalian tissues contain two types of cannabinoid receptors CB1 and CB2. The aim of our study was an evaluation of the influence of a single i.p. injection of a stable analogue of an endogenous cannabinoid anandamide--R-(+)-methanandamide (2.5 mg/kg) and CP 55,940 (0.25 mg/kg), which is an exogenous agonist of CB1 receptors, on the immunoreactivity of regulatory peptides, produced in rat thyroid C cells: calcitonin, CGRP, somatostatin and synaptophysin. This study indicates that a single injection of cannabinoids: R-(+)-methanandamide and CP 55,940 alters the immunoreactivity of regulatory peptides in thyroid parafollicular cells.

MeSH terms

  • Animals
  • Arachidonic Acids / pharmacology*
  • Calcitonin Gene-Related Peptide / metabolism
  • Cannabinoids / pharmacology*
  • Cyclohexanols / pharmacology
  • Endocannabinoids
  • Male
  • Polyunsaturated Alkamides
  • Rats
  • Rats, Wistar
  • Receptor, Cannabinoid, CB1 / drug effects
  • Receptor, Cannabinoid, CB1 / physiology
  • Receptor, Cannabinoid, CB2 / drug effects
  • Receptor, Cannabinoid, CB2 / physiology
  • Somatostatin / metabolism
  • Synaptophysin / metabolism
  • Thyroid Gland / drug effects
  • Thyroid Gland / physiology*

Substances

  • Arachidonic Acids
  • Cannabinoids
  • Cnr2 protein, rat
  • Cyclohexanols
  • Endocannabinoids
  • Polyunsaturated Alkamides
  • Receptor, Cannabinoid, CB1
  • Receptor, Cannabinoid, CB2
  • Synaptophysin
  • methanandamide
  • Somatostatin
  • 3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol
  • Calcitonin Gene-Related Peptide
  • anandamide